-+ 0.00%
-+ 0.00%
-+ 0.00%

APOLLOMICS ANNOUNCES TOP-LINE RESULTS FOR PHASE 3 BRIDGING TRIAL OF UPROLESELAN IN CHINA IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

Reuters·12/20/2024 13:00:00

Please log in to view news